According to a Chainalysis report, the grey market peptides industry is experiencing rapid growth in its use of cryptocurrencies. Cryptocurrency inflows into the industry reached $32 million in the first quarter of 2026, a 159% increase from $12 million in the previous quarter. The report notes that many suppliers are turning to Bitcoin and stablecoins for cross-border payments and settlements because traditional banks and payment institutions typically restrict transactions related to prescription compounds and unregulated substances. Larger suppliers, in particular, tend to use stablecoins to mitigate price volatility risk.